Ascendis Pharma A (ASND) EBT Margin (2014 - 2026)
Ascendis Pharma A (ASND) posted EBT Margin of 67.82% for the quarter ended Jun 30, 2026, up 89.97 percentage points from -22.15% a year earlier and up 87.35 percentage points from the prior quarter.
Ascendis Pharma A (ASND) EBT Margin (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Ascendis Pharma A was 9.25%, up 62.72 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -29.53%, up 62.45 percentage points from the prior year.
- Annual EBT Margin has increased for five consecutive years, with a five-year change of +5999.15 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Ascendis Pharma A's EBT Margin was -91.98% in the year ended Dec 31, 2024 (+85.79 pp), -177.77% in the year ended Dec 31, 2023 (+951.35 pp), -1129.12% in the year ended Dec 31, 2022 (+3807.16 pp) and -4936.28% in the year ended Dec 31, 2021 (+1092.40 pp).
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly EBT Margin since the quarter ended Mar 31, 2015.
- On a year-over-year basis, EBT Margin has increased in each of the last eight quarters, with an average year-over-year change of +101.38 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBT Margin in the past five years was the quarter ended Jun 30, 2022, with a gain of 11833.92 percentage points; the weakest was the quarter ended Sep 30, 2021, with a drop of 2802.20 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -19.54% (quarter ended Mar 31, 2026), -10.79% (quarter ended Dec 31, 2025) and -26.86% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Ascendis Pharma A | 14.48 Bn | 10.74 Bn | 362.22 Mn | 67.82% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.82% |
| Mar 31, 2026 | -19.54% |
| Dec 31, 2025 | -10.79% |
| Sep 30, 2025 | -26.86% |
| Jun 30, 2025 | -22.15% |
| Mar 31, 2025 | -92.68% |
| Dec 31, 2024 | -21.50% |
| Sep 30, 2024 | -169.76% |
| Jun 30, 2024 | -303.21% |
| Mar 31, 2024 | -134.03% |
| Dec 31, 2023 | -58.89% |
| Sep 30, 2023 | -336.38% |
| Jun 30, 2023 | -257.13% |
| Mar 31, 2023 | -326.35% |
| Dec 31, 2022 | -882.55% |
| Sep 30, 2022 | -1,106.10% |
| Jun 30, 2022 | -1,320.88% |
| Mar 31, 2022 | -1,834.46% |
| Dec 31, 2021 | -2,168.18% |
| Sep 30, 2021 | -7,218.60% |
Ascendis Pharma A EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();